Seasoned researcher and academician, Dr. Chinyere Ezeh-Ezemba, has shed light on the high value of lysine in medical intervention, highlighting its therapeutic potential in disease control and wound healing.
She made this assertion in a media statement recently, stating that lysine-producing microbes are emerging as therapeutic agents in wound healing and chronic disease care.
“Lysine is one of the nine amino acids the body does not produce on its own, and it plays a critical role in protein building, immune function, collagen formation, and absorption of calcium,” Dr.Ezeh-Ezemba explained.
According to Ezeh-Ezemba, lysine has emerged as a key player in therapeutic interventions, especially where cellular repair and immune regulation are concerned.
“Its application in therapy against viral infections, bone reinforcement, and tissue re-growth makes it a prime target for biotechnology,” she added.
Further added in her statement, she mentioned that these microbes can be used in various ways, including as probiotics or in external treatments such as bioactive wound dressings or lysine-enriched ointments.
“If used on wounds, lysine-releasing bacteria may offer a dual benefit: they stimulate local collagen production for tissue repair to occur more quickly and may have weak antimicrobial effects by altering the local environment, which avoids secondary infection,” Dr. Ezeh-Ezemba noted.
Beyond wound healing, the expert highlighted the potential of lysine in controlling chronic disease.
“Lysine has proven to have potential in sustaining immune function, inhibiting viral replication, and stabilising metabolic control,” she said,
She stated that genetically altered microbes that colonize the gut or skin and release lysine slowly over time could provide chronic therapeutic management for patients with diseases including chronic viral infections, immunodeficient wounds, and metabolic illnesses managed by amino acid profiles.
The potential applications of lysine-producing microbes are vast and varied.
She added in her statement that the initial-stage research is also investigating how lysine-producing probiotics can engage with the gut-brain axis, offering speculative but promising potential for future neurological and psychiatric use.
“This could open up new avenues for treatment and management of a range of diseases and conditions,” she said.
One of the key advantages of using lysine-producing microbes is their ability to deliver amino acid therapy precisely where it’s needed.
Maintaining microbial stability and lysine bioavailability under realistic conditions requires precision biodesign.
However, Dr. Ezeh-Ezemba believes that the benefits of this approach far outweigh the challenges.
“As science increasingly focuses on these microbial systems, we may soon be witnessing off-the-shelf medicines that take the best of biology and biotechnology and turn healthy microbes into microscopic healers,” she concluded.
Dr. Ezeh-Ezemba is a seasoned academician with a strong background in medical research, contributing to groundbreaking studies and innovations in disease control and wound healing.